ECM
PFE icon

EMC Capital Management’s Pfizer PFE Stock Holding History

EMC Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,923
Closed -$18 – 295
2023
Q2 		$18 Buy
17,923
+16,852
+1,573% +$656K 0.01% 268
2023
Q1 		$44K Buy
1,071
+11
+1% +$475 0.04% 258
2022
Q4 		$54K Buy
1,060
+8
+0.8% +$384 0.05% 255
2022
Q3 		$52K Buy
1,052
+9
+0.9% +$437 0.05% 244
2022
Q2 		$55K Buy
1,043
+9
+0.9% +$459 0.05% 262
2022
Q1 		$54K Buy
1,034
+8
+0.8% +$415 0.04% 279
2021
Q4 		$61K Buy
1,026
+8
+0.8% +$396 0.03% 98
2021
Q3 		$45K Buy
1,018
+8
+0.8% +$354 0.03% 112
2021
Q2 		$46K Buy
1,010
+10
+1% +$389 0.03% 112
2021
Q1 		$36K Hold
1,000
– – 0.03% 103
2020
Q4 		$37K Buy
+1,000
New +$36.7K 0.03% 98

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EMC Capital Management's PFE Position: Q3 2023 in Review

EMC Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 17,923 shares — an estimated $18 sold.

EMC Capital Management first reported a position in PFE in Q4 2020 and held it in 11 quarters. The position peaked at $61K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • EMC Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • EMC Capital Management sold 17,923 Pfizer shares in Q3 2023, an estimated $18.
  • EMC Capital Management first reported a position in Pfizer in Q4 2020 and held it in 11 quarters.
  • EMC Capital Management's Pfizer position peaked at $61K in Q4 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on EMC Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.